Logo.png
Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
13. Januar 2025 13:00 ET | DelveInsight Business Research LLP
New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Logo.png
Rare Endocrinology and Metabolic Disorders Market Analysis: Emerging Trends and Future Outlook of Hypophosphatasia, Congenital Adrenal Hyperplasia, and Severe Hypertriglyceridemia | DelveInsight
09. Januar 2025 13:00 ET | DelveInsight Business Research LLP
New York, USA, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Rare Endocrinology and Metabolic Disorders Market Analysis: Emerging Trends and Future Outlook of Hypophosphatasia, Congenital Adrenal Hyperplasia,...
Logo.png
Latest Published 4 Rare Neurological Disorders Market Reports by DelveInsight: Amyotrophic Lateral Sclerosis, Developmental and Epileptic Encephalopathies, Primary Ciliary Dyskinesia, and Chronic Inflammatory Demyelinating Polyneuropathy
09. Januar 2025 13:00 ET | DelveInsight Business Research LLP
New York, USA, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Latest Published 4 Rare Neurological Disorders Market Reports by DelveInsight: Amyotrophic Lateral Sclerosis, Developmental and Epileptic...
Logo.png
Stay Ahead in Ophthalmology: Strategic Market Insights for Myopia Assessment & Forecasting | DelveInsight
20. Dezember 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Stay Ahead in Ophthalmology: Strategic Market Insights for Myopia Assessment & Forecasting | DelveInsight A  case study on how a leading company...
Logo.png
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight
19. Dezember 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight Rare genetic disorders affect approximately 1 in...
Logo.png
MET Targeting Therapies Market Set for Significant Growth by 2034: Key Trends and Insights | DelveInsight
18. Dezember 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- MET Targeting Therapies Market Set for Significant Growth by 2034: Key Trends and Insights | DelveInsight  The MET targeting therapies market is...
Logo.png
Rare Skin Disorders Market: Key Insights into Future Outlook and Trends of Pemphigus Vulgaris, Epidermolysis Bullosa, Palmoplantar Pustulosis, and Prurigo Nodularis | DelveInsight
17. Dezember 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Rare Skin Disorders Market: Key Insights into Future Outlook and Trends of Pemphigus Vulgaris, Epidermolysis Bullosa, Palmoplantar Pustulosis, and...
Logo.png
Latest Published 5 Rare Eye Diseases Market Reports by DelveInsight: Retinitis Pigmentosa, Stargardt Disease, Ocular Melanoma, Uveitis, and Neurotrophic Keratitis
16. Dezember 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Latest Published 5 Rare Eye Diseases Market Reports by DelveInsight: Retinitis Pigmentosa, Stargardt Disease, Ocular Melanoma, Uveitis, and...
Logo.png
Parkinson's Disease Market is Expected to Showcase a Significant Growth at a CAGR of 5.8% During the Study Period (2020–2034) | DelveInsight
12. Dezember 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Parkinson's Disease Market is Expected to Showcase a Significant Growth at a CAGR of 5.8% During the Study Period (2020–2034) | DelveInsight  The...
Logo.png
Alcohol Use Disorder Market Set for Remarkable Growth During the Study Period (2020–2034) | DelveInsight
11. Dezember 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alcohol Use Disorder Market Set for Remarkable Growth During the Study Period (2020–2034) | DelveInsight  DelveInsight’s analysts estimate that the...